Format

Send to

Choose Destination
See comment in PubMed Commons below
Mol Psychiatry. 2015 Feb;20(1):18-22. doi: 10.1038/mp.2014.23. Epub 2014 Mar 25.

Estrogen receptor β and Liver X receptor β: biology and therapeutic potential in CNS diseases.

Author information

1
Center for Nuclear Receptors and Cell Signaling, University of Houston, Houston, TX, USA.
2
1] Center for Nuclear Receptors and Cell Signaling, University of Houston, Houston, TX, USA [2] Department of Biosciences and Nutrition, Novum, Karolinska Institutet, Stockholm, Sweden.

Abstract

In the last decade of the twentieth century, two nuclear receptors were discovered in our laboratory and, very surprisingly, were found to have key roles in the central nervous system. These receptors have provided some novel insights into the etiology and progression of neurodegenerative diseases and anxiety disorders. The two receptors are estrogen receptor beta (ERβ) and liver X receptor beta (LXRβ). Both ERβ and LXRβ have potent anti-inflammatory activities and, in addition, LXRβ is involved in the genesis of dopaminergic neurons during development and protection of these neurons against neurodegeneration in adult life. ERβ is involved in migration of cortical neurons and calretinin-positive GABAergic interneurons during development and maintenance of serotonergic neurons in adults. Both receptors are present in magnocellular neurons of the hypothalamic preoptic area including those expressing vasopressin and oxytocin. As both ERβ and LXRβ are ligand-activated transcription factors, their ligands hold great potential in the treatment of diseases of the CNS.

PMID:
24662928
DOI:
10.1038/mp.2014.23
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Nature Publishing Group
    Loading ...
    Support Center